RBC Europe’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$26K Hold
125
﹤0.01% 390
2022
Q1
$30K Sell
125
-495
-80% -$116K ﹤0.01% 408
2021
Q4
$142K Sell
620
-432
-41% -$95.1K 0.01% 246
2021
Q3
$203K Sell
1,052
-801
-43% -$162K 0.01% 299
2021
Q2
$394K Sell
1,853
-5
-0.3% -$1.06K 0.02% 228
2021
Q1
$379K Buy
1,858
+575
+45% +$113K 0.02% 211
2020
Q4
$234K Buy
1,283
+238
+23% +$40.5K 0.01% 258
2020
Q3
$175K Buy
1,045
+27
+3% +$4.55K 0.01% 268
2020
Q2
$165K Sell
1,018
-96
-9% -$17.2K 0.01% 268
2020
Q1
$193K Hold
1,114
0.02% 210
2019
Q4
$224K Hold
1,114
0.02% 238
2019
Q3
$235K Hold
1,114
0.02% 224
2019
Q2
$216K Buy
1,114
+834
+298% +$154K 0.02% 241
2019
Q1
$46.1K Buy
280
+34
+14% +$6.01K 0.01% 481
2018
Q4
$46.3K Hold
246
0.01% 453
2018
Q3
$41.9K Buy
246
+166
+208% +$27.9K ﹤0.01% 521
2018
Q2
$13.1K Sell
80
-600
-88% -$98K ﹤0.01% 787
2018
Q1
$110K Buy
+680
New +$108K 0.01% 328

Other funds holding CME

RBC Europe's CME Position: Q2 2022 in Review

RBC Europe held its CME Group (CME) position steady in Q2 2022 at 125 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #390.

RBC Europe first reported a position in CME in Q1 2018 and has held it in 18 quarters since. The position peaked at $394K in Q2 2021. 1,159 funds tracked by Wall St. Rank hold CME as of Q2 2022.

  • RBC Europe held 125 shares of CME Group worth $26K as of Q2 2022.
  • RBC Europe left its CME Group share count unchanged in Q2 2022.
  • CME Group made up ﹤0.01% of RBC Europe's portfolio in Q2 2022, its #390 holding.
  • RBC Europe first reported a position in CME Group in Q1 2018 and has held it in 18 quarters since.
  • RBC Europe's CME Group position peaked at $394K in Q2 2021.
  • 1,159 funds tracked by Wall St. Rank held CME Group as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.